جست‌وجوی استاد و پژوهشگر

Emanuele De Paoliمشاهده پروفایل

دانشیار

• Plant Genomics
• Epigenomics
• Plant Breeding
• +۴ مورد دیگر

Emanuele De Paoli is an Associate Professor of Agricultural Genetics at the University of Udine, Department of Agricultural, Food, Environmental and Animal Sciences (DI4A). His academic career includes postdoctoral positions at the University of Delaware's Delaware Biotechnology Institute (2007-2010) and Istituto Agrario di San Michele all'Adige (2010-2011) before joining the University of Udine as a Researcher in 2011, where he has advanced to Associate Professor. Dr. De Paoli's research focuses on plant genomics and epigenomics, plant breeding and biotechnology, and bioinformatics. His work spans multiple plant species including grapevine, poplar, and various agricultural crops, with particular emphasis on understanding genetic and epigenetic mechanisms underlying stress responses, phenological development, and adaptation to changing environmental conditions. His laboratory investigates DNA methylation patterns, transposable element activity, and gene regulation networks that influence plant development and resilience. His publication record shows strong trends in climate change adaptation research, particularly regarding how rising temperatures affect grapevine phenology and dormancy cycles. He has developed significant expertise in advanced genomic techniques including ddRAD sequencing, methylome analysis, and CRISPR-Cas9 genome editing. His work bridges fundamental molecular biology with practical agricultural applications, especially in developing climate-resilient crop varieties. Dr. De Paoli teaches graduate-level courses including Genetic Technologies for Plant Innovation and Plant Breeding in the Biotechnology and Agricultural Science Master's programs. He is an active member of the Italian Society of Agricultural Genetics (SIGA) and maintains extensive research collaborations across Europe as evidenced by his numerous co-authored publications. His research has been supported through various academic and institutional channels, enabling his laboratory to pursue innovative approaches to plant genomics and breeding.

John Essigmannمشاهده پروفایل

استاد

• DNA Damage
• Mutagenesis
• Carcinogenesis
• +۴ مورد دیگر

John Essigmann is the William R. (1956) and Betsy P. Leitch Professor in Residence of Chemistry at the Massachusetts Institute of Technology, with joint appointments in the Department of Chemistry and Department of Biological Engineering. He previously served as Director of the Center for Environmental Health Sciences (2012-2019) and Associate Head of the Department of Chemistry (until 2012). Currently, he directs the MIT T32 Training Grant in Toxicology and maintains an active research program focused on DNA damage mechanisms. His educational background includes undergraduate studies at Northeastern University and a Ph.D. from MIT under Professor Gerald Wogan, a pioneer in toxicology. His doctoral work investigated metabolic activation and DNA binding of aflatoxin B1 and related fungal toxins. Essigmann's research centers on understanding how DNA lesions caused by environmental toxins and chemotherapeutic drugs lead to mutations, cancer, and cell death. His laboratory pioneered methods to synthesize oligonucleotides containing specific DNA adducts and introduce them into viral genomes to study mutational outcomes. This work has provided fundamental insights into carcinogenesis mechanisms and informed the development of anticancer strategies like 'lethal mutagenesis.' His research spans molecular toxicology, DNA repair mechanisms, mutagenesis, and the molecular etiology of human cancer. Analysis of his recent publications reveals consistent focus on DNA damage mechanisms, with particular emphasis on environmental carcinogens like nitrosamines and aflatoxins. His work increasingly integrates advanced detection technologies, next-generation sequencing, and structural biology approaches to understand mutational signatures and DNA repair pathways. The research shows strong translational potential in cancer prevention, early detection of carcinogens, and development of novel therapeutic strategies. National Cancer Institute Outstanding Investigator Award (1989) Arthur C. Smith Award (1998, 2020) Mutation Research Award for Scientific Excellence (2000) Susan B. Komen Breast Cancer Foundation Award (2000) Thailand's Gold Medal (2004) MERIT Award from the National Cancer Institute (2008) Martin Luther King, Jr., Leadership Award (2009) Founders Award from the Chemical Toxicology Division of the American Chemical Society (2021) Essigmann has mentored numerous graduate students and postdoctoral researchers, with Dr. Bogdan Fedeles representing one prominent example who has published landmark reviews from the Essigmann Lab. His research has been consistently supported by major NIH grants, including a decade-long NCI Outstanding Investigator Award and the current T32 Training Grant in Toxicology. He has served on numerous national review panels, including as past chair of the NIH Chemical Pathology Study Section and service on the Council of the National Institute of Environmental Health Sciences. The Essigmann Lab, housed within MIT's Department of Chemistry, maintains strong collaborative ties with other MIT research groups including the Swager Lab (nanosensors for carcinogen detection). The lab has historically maintained connections with Thailand through research and teaching at the Chulabhorn Research Institute and other Thai institutions, reflecting Essigmann's international recognition for work on problems affecting the developing world.

John Bainesمشاهده پروفایل

استاد

• Evolutionary Genomics
• Host-Microbiome Interactions
• Bacterial Evolution
• +۳ مورد دیگر

John Baines holds the position of Professor in Evolutionary Genomics at Kiel University (Christian-Albrechts-Universität zu Kiel) and is a Principal Investigator at the Max Planck Institute for Evolutionary Biology in Plön, Germany. Additionally, he holds an SH Excellence Chair, serves as the speaker of the Clinician Scientist Program in Evolutionary Medicine, and coordinates the Evolutionary Medicine function area within the master's program Medical Life Science at Kiel University. His laboratory is based at the Institute for Experimental Medicine (IEM) located in Kiel, where he leads research on the interplay between host evolution and microbiome dynamics. Professor Baines' research program centers on Evolutionary Genomics and Host-Microbiome Interactions, with a particular emphasis on understanding bacterial evolution in the context of chronic inflammatory diseases. His work investigates how host-microbiome metabolic interactions change with aging and disease, using mouse models to study inflammatory bowel disease, anorexia nervosa, and other conditions. He integrates genomic, metagenomic, and computational approaches to dissect the mechanisms by which host genetics and environmental factors shape the microbiome and influence disease progression and treatment outcomes. Analysis of his publication record from 2016 to 2025 shows a consistent and growing body of work in microbiome research, particularly focused on gut microbiota in health and disease. His studies frequently address the evolutionary aspects of host-microbiome co-adaptation, the impact of host genetic variation (such as in NOD2 and vitamin D receptor genes) on microbiome composition, and the clinical implications of microbiome dynamics in diverse patient populations. This research spans multiple disciplines including genomics, immunology, and computational biology, reflecting a highly interdisciplinary approach. Based on the provided information, no specific scientific awards, prizes, or fellowships are attributed to Professor Baines. However, his research is supported by competitive funding from the Deutsche Forschungsgemeinschaft (DFG), indicating recognition of his work by the scientific community. Professor Baines actively mentors students and researchers through his role in the Clinician Scientist Program and as coordinator of the Evolutionary Medicine component in the Medical Life Science master's program. His research group receives funding from the DFG for projects investigating bacterial evolution during chronic inflammation and the potential for restorative therapies based on ancestral bacterial states. These grants support a range of activities from basic research to translational applications. The Baines laboratory, part of the Evolutionary Medicine group at the Institute for Experimental Medicine, Kiel University, collaborates extensively with the Max Planck Institute for Evolutionary Biology and other institutions including the Research Center Borstel and the University Medical Center Schleswig-Holstein. Current projects, such as the investigation of bacterial evolution in inflammatory bowel disease (Phases 1 and 2 of project P10), aim to translate evolutionary insights into novel therapeutic strategies for restoring healthy microbiome states.

Elena Maestriمشاهده پروفایل

استاد

• Environmental Biotechnology
• Phytoremediation
• Molecular Traceability for Food Safety
• +۲ مورد دیگر

Elena Maestri is a Full Professor in the Department of Chemical, Life and Environmental Sustainability Sciences at the University of Parma, with leadership roles including President (2016-2021) and Deputy President (2022-present) of the Biotechnology Degree Course, and Coordinator of the PhD in Biotechnology and Biosciences (2024-present). She serves on editorial boards for Environmental Science and Pollution Research, International Journal of Phytoremediation, and Agronomy. Her educational background includes a cum laude Degree in Biological Sciences from the University of Pavia (1980-1985) and a PhD in Genetic Sciences from the University of Parma (1985-1989). Her research focuses on Environmental Biotechnology , specializing in phytoremediation of heavy metals/nanomaterials using higher plants, molecular traceability for food safety/authenticity, plant genetic responses to environmental stressors (thermal, drought, contaminants), and circular economy applications through biochar production. Her work integrates genomics, proteomics, and molecular marker analysis to develop sustainable agricultural solutions. Recent publications (2024-2025) demonstrate a strong trend toward field-tested applications of biochar and microbial consortia for soil remediation, crop resilience, and water management, particularly in Mediterranean agricultural systems like rice paddies, tomato fields, and olive groves. She has received significant recognition for scholarly contributions: 2016 Sentinel of Science Award for Environmental Science (top 10% reviewers) 2017 Top Reviewers for Multidisciplinary 2018 Top Reviewers for Environment/Ecology As an academic leader, she coordinates PhD programs, serves on the EU GREEN Alliance Steering Committee (Cluster 2, WP3), and directs National Scientific Degrees Plan activities for Biology/Biotechnology. Her research is supported through consortia including SITEIA.PARMA, INSTM, CIDEA, and CINSA. She leads interdisciplinary teams within SITEIA.PARMA (Agri-food Safety), INSTM (Materials Science), CIDEA (Energy/Environment), and CINSA (Environmental Sciences), driving innovation in sustainable agriculture and environmental remediation technologies.

Katherine T. Millsمشاهده پروفایل

دانشیار

• Cardiovascular Disease Epidemiology
• Renal Disease Epidemiology
• Implementation Science
• +۵ مورد دیگر

Katherine T. Mills is an Associate Professor in the Epidemiology Department at Tulane University's School of Public Health and Tropical Medicine. Her research focuses on cardiovascular and renal disease epidemiology, implementation science, and health disparities, with particular emphasis on blood pressure control interventions and chronic kidney disease. Dr. Mills received her PhD in Epidemiology from Tulane University, completed a postdoctoral fellowship in cardiovascular disease epidemiology at Johns Hopkins University, earned an MSPH in Epidemiology from the University of North Carolina at Chapel Hill, and completed her undergraduate studies in Chemistry at Colorado College. Her research program spans multiple domains of public health and clinical epidemiology. Dr. Mills has established herself as a leader in studies examining the relationship between cardiovascular disease, kidney function, and health disparities. She has conducted extensive research on implementation science approaches to improve blood pressure control, particularly in underserved populations. Her work also investigates health outcomes in chronic kidney disease patients, including progression to end-stage renal disease, cardiovascular events, and mortality. Through her research, Dr. Mills has contributed significantly to understanding how social determinants of health impact cardiovascular outcomes and how community-based interventions can reduce health disparities. She has been particularly active in engaging Black churches as venues for cardiovascular health interventions. Analysis of Dr. Mills' recent publications reveals a strong focus on cardiovascular epidemiology, kidney disease outcomes, and implementation science for hypertension control. Her work frequently employs advanced statistical methods and large cohort studies, particularly the Chronic Renal Insufficiency Cohort (CRIC) study. She has published extensively on topics including blood pressure management, kidney disease progression, cardiovascular risk factors, and health disparities in minority populations. Her research often examines the intersection of social determinants of health with clinical outcomes. Dr. Mills has received numerous scientific awards including: 2020: Outstanding Achievement in Receiving Your First R01 Award 2018: Young Investigator Travel Award, NIH, NIGMS Seventh Biennial National IdeA Symposium of Biomedical Research Excellence (NISBRE) 2017: Sandra A. Daugherty Award for Excellence in Cardiovascular Disease for Hypertension Epidemiology, American Heart Association Council on Epidemiology and Prevention 2016: Award for Excellence in Research and Presentation by a Postdoctoral Fellow, Health Sciences Research Days, Tulane University 2015-2016: NIH/NHLBI T32 Cardiovascular Disease Epidemiology Training Program, Johns Hopkins University 2014: Dorothy R. LeBlanc Memorial Scholarship Award, Tulane University 2010-2012: Dean's Research Council Scholarship, Tulane University Dr. Mills has secured significant NIH funding for her research on blood pressure control interventions and health disparities. She has mentored numerous students and collaborated extensively with interdisciplinary teams across Tulane and other institutions. Her work on church-based interventions for cardiovascular health has been particularly influential in addressing racial health disparities. She has developed and tested multicomponent implementation strategies that engage community health workers and faith-based organizations to improve blood pressure control in low-income communities. Dr. Mills is actively engaged with the Chronic Renal Insufficiency Cohort (CRIC) study and has led multiple analyses examining cardiovascular outcomes in patients with chronic kidney disease. She collaborates with interdisciplinary teams including nephrologists, cardiologists, biostatisticians, and community health workers to address complex questions in cardiovascular and kidney disease epidemiology. Her current research focuses on identifying which populations benefit most from intensive blood pressure interventions and how social determinants of health influence treatment effectiveness.

• Environmental Microbiology
• Microbial Genetics
• Marine Microbiology
• +۳ مورد دیگر

Francesca Malfatti is an Associate Professor of Microbiology at the Department of Life Sciences (DSV) of the University of Trieste. She serves as a member of the Department's Board and multiple Boards of Studies for degree programs including Science and Technology for Environment and Nature (SM40), Biological Sciences and Technologies (SM51), Functional Genomics (SM53), and Marine and Coastal Environmental Science (SM44/SM44A). Her research focuses on environmental microbiology and genetics, particularly at the atmosphere-ocean interface. She leads the Environmental Microbiology Laboratory (EMLab) and serves as Principal Investigator for the FEMTO project (Focused rEsistome-Mobilome genes in aTmosphere-Ocean continuum), funded by the Italian Ministry of University and Research (2023-2025). Her work also encompasses Antarctic marine microbiology through the IBIZA project and viral-host interactions via the VirHoX initiative. Analysis of her recent publications reveals a strong emphasis on microbial gene transfer mechanisms, antibiotic resistance dynamics across environmental compartments, and the role of atmospheric processes in microbial dispersal. Her research bridges marine microbiology, atmospheric science, and genetic analysis to understand microbial community dynamics across interconnected environmental systems. Dr. Malfatti actively participates in multiple research initiatives including Ecosistema Innovazione iNEST, SAVEMAR, and several international collaborations focused on environmental microbiology and marine ecosystem health.

Paul A. Rufoمشاهده پروفایل

استادیار

• Pediatric Gastroenterology
• Inflammatory Bowel Disease
• Ulcerative Colitis
• +۷ مورد دیگر

Dr. Paul A. Rufo is an Attending Physician in the Division of Gastroenterology, Hepatology and Nutrition at Boston Children's Hospital and serves as Assistant Professor of Pediatrics at Harvard Medical School. He also holds the position of Program Director for the HMS Fellowship in Pediatric Gastroenterology and Nutrition, demonstrating his commitment to training the next generation of specialists in this field. Undergraduate: Harvard University (1985) Medical School: University of Massachusetts Medical School (1990) Internship & Residency: Johns Hopkins Hospital (1991-1993) Fellowships: Pediatric Gastroenterology and Cell Biology at Boston Children's Hospital (1994-1996), Pfizer Fellowship in Clinical Investigation at Beth Israel Deaconess Medical Center (2002) Dr. Rufo's research program focuses on developing novel treatments and diagnostic tools for inflammatory intestinal diseases in children and adults. His work spans from basic science investigations to clinical applications, with particular emphasis on the therapeutic potential of clotrimazole for inflammatory conditions like pouchitis and ulcerative colitis. His team has made significant contributions to understanding fecal biomarkers, particularly lactoferrin, for assessing disease activity in inflammatory bowel disease (IBD). His research program demonstrates a strong translational approach, moving discoveries from bench to bedside. Analysis of Dr. Rufo's recent publications reveals a consistent focus on optimizing treatment strategies for pediatric IBD, with particular attention to ulcerative colitis management, novel therapeutic approaches including microbiome-based interventions, and addressing healthcare disparities in pediatric gastroenterology. His work spans clinical trials, biomarker discovery, and innovative approaches to diagnostic assessment, demonstrating his comprehensive approach to improving outcomes for children with gastrointestinal disorders. Dr. Rufo serves as Program Director for the Harvard Medical School Fellowship in Pediatric Gastroenterology and Nutrition, indicating his leadership role in medical education. While specific grant details aren't provided in the available information, his extensive publication record spanning decades suggests sustained research funding supporting his investigative work in pediatric inflammatory bowel diseases. As part of Boston Children's Hospital's Division of Gastroenterology, Hepatology and Nutrition - one of the nation's leading pediatric GI programs - Dr. Rufo collaborates with a multidisciplinary team of over 45 specialized physicians and 60 clinicians including social workers, dietitians, and psychologists. His research laboratory work has focused on the anti-secretory and anti-inflammatory properties of clotrimazole, with ongoing clinical translation efforts evaluating its therapeutic potential for conditions like pouchitis.

• Conservation Genetics
• Population Genetics
• Evolutionary Biology
• +۶ مورد دیگر

Professor Jacob Höglund is a distinguished academic at Uppsala University, where he serves as Professor of Animal Conservation Biology in the Department of Ecology and Genetics, specializing in Animal Ecology. His research focuses on the importance of genetic variation for the persistence of small and fragmented populations, with primary emphasis on vertebrates though he has also contributed to insect conservation projects. Höglund has held significant positions at Uppsala University, including: Professor, Animal Conservation Biology, Department of Ecology and Genetics (2006-present) Head of Department, Division of Population Biology and Conservation Biology (1999-2005) Senior lecturer/Associate Professor in Evolutionary Biology, Department of Zoology (1993-1998) Assistant Professor, Department of Zoology (1989-1993) Höglund's research program spans conservation genetics, population genomics, and evolutionary biology, with particular emphasis on understanding how genetic variation influences population viability. His work frequently examines MHC (Major Histocompatibility Complex) diversity, population structure, and the application of genomic approaches to conservation challenges. While primarily focused on avian species (particularly grouse and other game birds), his research extends to amphibians, mammals, and insects, reflecting a broad ecological perspective on conservation genetics. His recent publications reveal a strong trend toward applying cutting-edge genomic techniques to conservation problems. Höglund has been instrumental in developing chromosome-level genome assemblies for threatened species, analyzing population structure and genetic diversity, and investigating the impacts of inbreeding and outbreeding depression. His work often combines field studies with sophisticated genomic analyses to address critical questions in wildlife conservation. Höglund has made significant contributions to bridging the gap between genomic research and practical conservation applications, helping establish frameworks for using genomic data in conservation decision-making for species with small or fragmented populations. His collaborative research spans multiple continents and involves numerous international partners, reflecting the global relevance of his work in conservation genomics.

Alexander Khorutsمشاهده پروفایل

استاد

• Gastroenterology
• Hepatology
• Microbiome Research
• +۳ مورد دیگر

Dr. Alexander Khoruts is a Professor in the Department of Medicine at the University of Minnesota , where he serves as Section Lead for Luminal GI MEC and Director of the UMN Microbiota Therapeutics Program . His academic roles focus on advancing microbiota-based therapies for gastrointestinal and systemic diseases. Primary Affiliation: Division of Gastroenterology, Hepatology and Nutrition Leadership: UMN Microbiota Therapeutics Program Dr. Khoruts’ research spans fecal microbiota transplantation (FMT) , microbial dysbiosis , and gut-liver axis interactions. His work examines how microbiome alterations impact conditions like inflammatory bowel disease (IBD) , hepatic encephalopathy , and post-transplant complications . Key themes include microbial engraftment dynamics, antibiotic resistance gene transfer, and metabolomic profiling. Recent publications highlight FMT applications in ulcerative colitis , cirrhosis , and autism , with technical innovations in metagenomic source tracking and microbial formulation development . He actively investigates microbiome contributions to acute myeloid leukemia and pulmonary arterial hypertension outcomes.

Michele K. Nishiguchiمشاهده پروفایل

استاد

• Microbial Symbiosis
• Evolutionary Biology
• Marine Biology
• +۴ مورد دیگر

Michele K. Nishiguchi serves as Professor in the Department of Molecular and Cell Biology within the School of Natural Sciences at the University of California, Merced. Her research program centers on marine symbiosis evolution, specifically investigating the mutualistic relationship between sepiolid squids and Vibrio bacteria as a model system for understanding host-symbiont specificity, population dynamics, and environmental adaptation. Current affiliations include leadership of the Nishiguchi Lab and active participation in collaborative research initiatives addressing climate change impacts on symbiotic systems. Her primary research focuses on the molecular mechanisms governing squid-Vibrio symbiosis, examining how environmental factors and genetic determinants influence symbiont recognition, competitive exclusion, and cospeciation. Key areas include Vibrio population genetics, biofilm dynamics in host colonization, T6SS-mediated bacterial competition, and thermal stress responses in symbiotic partnerships. Recent work leverages CRISPR-based tools, transcriptomics, and genomic approaches to dissect symbiosis regulation across marine ecological niches. Analysis of her 15 most recent publications reveals a strong emphasis on environmental drivers of symbiosis (47%), molecular mechanisms of host-symbiont interaction (33%), and methodological innovations in symbiosis research (20%). Dominant themes include bacterial competition within host environments, climate change impacts on symbiotic stability, and evolutionary adaptations in symbiont transmission. Her work consistently bridges molecular microbiology with ecological and evolutionary frameworks. Scientific recognition includes: NSF CAREER Award for research on individual variation in dispersal through social landscapes Nishiguchi actively mentors undergraduate and graduate researchers, with 15 documented students in her 2022-2023 lab cohort including UROC and NSF REU participants. Current funding includes the SICBEDU collaborative grant (2024) focused on equity in integrative biology education and the BII: INSITE climate adaptation initiative (2022). Her grant portfolio demonstrates dual commitment to symbiosis research and broadening participation in STEM. The Nishiguchi Lab operates as a multidisciplinary research hub investigating marine symbiosis through molecular, ecological, and evolutionary approaches. Current projects examine biofilm-predator interactions, Vibrio genomics across host species, and climate stress impacts on symbiotic fitness, utilizing the squid-Vibrio model system's experimental tractability for both basic and applied research in microbiome science.

Jeffrey Chengمشاهده پروفایل

دانشیار

• Pediatric Otolaryngology
• Pediatric Airway Disorders
• Chronic Ear Diseases
• +۴ مورد دیگر

Jeffrey Cheng, MD, is an Associate Professor in the Department of Head and Neck Surgery and Communication Sciences at Duke University, with a secondary appointment in Pediatrics. He specializes in pediatric otolaryngology, focusing on airway disorders, chronic ear diseases, and anterior skull base surgery through comprehensive multidisciplinary care. His educational background includes: B.A. from Brown University (2002) M.D. from Brown University (2006) Otolaryngology Residency at Icahn School of Medicine at Mount Sinai (2006-2011) Pediatric Otolaryngology Fellowship at Children's Hospital of Philadelphia (2011-2013) Dr. Cheng's research spans pediatric otolaryngology with a current emphasis on quality and safety systems. As Medical Director for Quality and Safety in Duke Children's Surgery Program, he drives initiatives to reduce clinical harms through process optimization and culture-building in surgical environments. His work integrates clinical outcomes with system-level healthcare improvements. Analysis of his 50+ publications reveals dominant themes in tonsillectomy safety, airway management, and quality metrics across pediatric ENT. Recent work connects clinical guidelines, opioid stewardship, and microbiome research to enhance surgical protocols, demonstrating consistent focus on evidence-based practice evolution in pediatric care. He serves as Principal Investigator for a National Institute of Allergy and Infectious Diseases grant (2023-2028) on "Clinical and host microbiome features in acute otitis media". While formal advisee lists aren't provided, his residency program involvement indicates active mentorship of surgical trainees. Dr. Cheng co-leads Duke's integrated pediatric aerodigestive, hearing loss, and skull base programs, collaborating with pulmonology, gastroenterology, and neurosurgery teams to address complex airway and cranial base conditions in children.

Margherita Cantornaمشاهده پروفایل

استاد

• Molecular Immunology
• Vitamin D in Immune Regulation
• Inflammatory Bowel Disease (IBD)
• +۴ مورد دیگر

Dr. Margherita Cantorna is a Distinguished Professor of Molecular Immunology at the Department of Veterinary and Biomedical Sciences , Pennsylvania State University, and serves as Director of the Center for Molecular Immunology and Infectious Disease . She is affiliated with the Huck Institutes of the Life Sciences and leads a research program at the intersection of nutrition and immune function. Specializes in vitamin D and A's roles in immune regulation Focuses on autoimmune diseases like Inflammatory Bowel Disease (IBD) and Multiple Sclerosis (MS) Investigates gut microbiota interactions with dietary components Research Highlights: Her work demonstrates that developmental vitamin D deficiency exacerbates autoimmune disease susceptibility, with key findings in T cell differentiation , innate lymphoid cell function , and microbiome modulation . Recent publications span topics from vitamin D receptor signaling in hematopoiesis to nutritional strategies for infectious disease resistance . Developed novel VDR reporter mouse models Identified critical roles for vitamin D in IL-22 production and pathogen clearance Explored dietary fiber and mushroom impacts on gut immunity Lab Members: Includes graduate student Juhi Arora and collaborates with researchers across immunology, microbiology, and nutritional sciences. The Cantorna Lab employs cutting-edge transcriptomics and germ-free animal models to dissect diet-immune interactions.

Caitlin Dreisbachمشاهده پروفایل

استادیار

• Women's Health
• Pregnancy and Obstetrics
• Data Science in Nursing
• +۳ مورد دیگر

Caitlin Dreisbach, PhD, RN is an Assistant Professor at the University of Rochester School of Nursing with a dual affiliation at the Goergen Institute for Data Science. She maintains active clinical practice on the high-risk obstetrics unit at Strong Memorial Hospital while leading interdisciplinary research at the intersection of nursing science and data analytics. Her educational background includes a PhD in Nursing from the University of Virginia (2020), BSN from Johns Hopkins University (2013), and undergraduate studies at Cornell University. Her research interests span women's lifelong health trajectories , quantitative clinical assessment during pregnancy , microbiome dynamics , and social determinants of health in reproductive outcomes. She employs advanced data science techniques including natural language processing, machine learning, and microbiome analysis to address complex questions in maternal-child health. Analysis of her 15 most recent publications reveals a strong focus on leveraging large-scale datasets (particularly the All of Us Research Program) to investigate pregnancy outcomes, symptom science, and chronic disease patterns. Key methodological themes include predictive modeling of birth outcomes, extraction of clinical data from unstructured notes, and analysis of microbiome-diet interactions during gestation. Scientific awards and recognition include: Josephine Craytor Nurse Faculty Award (2024) Most Promising New Investigator (2023) Phyllis J. Verhonick Dissertation Award (2020) Wood Family Award for Data Science (2018) The Raven Society membership (2017) Dr. Dreisbach serves as Principal Investigator for multiple funded projects including an NIH/NINR grant on neural network approaches to fetal weight estimation (2022-2025) and a Heilbrunn Foundation grant examining surgical weight management before pregnancy (2024-2026). Her lab (DreisbachLab) develops open-source tools for reproductive health research, including the GAP_Projection repository for birthweight prediction algorithms. She also contributes as a data science consultant on projects like the Significance of Symptom Onset-To-Angiography Time study at CTSI. Her work bridges clinical practice, data science innovation, and nursing education through initiatives advancing data competencies for PhD students and exploring implications of generative AI in nursing science.

• Neonatology
• Pediatric Health
• Nutritional Science
• +۳ مورد دیگر

Dr. Fordjour Lawrence is a Clinical Assistant Professor at SUNY Downstate Medical Center in Brooklyn, New York, affiliated with the Department of Pediatrics. He serves as the Director of the High-Risk Neurodevelopmental NICU Follow-up Clinic and Associate Program Director of the Pediatric Residency Program. Education: Danylo Halytsky Lviv National Medical University, Ukraine; Internship and Residency at Long Island College Hospital/Beth Israel Medical Center; Fellowship at New York University. Dr. Lawrence’s research focuses on neonatal nutrition, gut immunology in preterm newborns, maternal and neonatal obesity, gestational diabetes effects on outcomes, and neurodevelopmental outcomes of preterm babies. He also leads global health initiatives to improve neonatal care in low- and middle-income countries. His recent publications explore adverse outcomes linked to maternal obesity in inner-city populations, competency goals for residents, and antibiotic effects on gut-derived short-chain fatty acids in translational models.

• Nephrology
• Biomineralization
• Health Informatics
• +۳ مورد دیگر

Jessica Saw serves as a Teaching Professor at the Carle Illinois College of Medicine, University of Illinois Urbana-Champaign, where she directs the Renal program within Biomedical and Translational Sciences. Her instructional responsibilities include teaching Renal (BSE 633) and Human Anatomy & Physiology Laboratory courses (MCB 245/247), emphasizing hands-on medical education for future physicians. Her research spans nephrology, biomineralization, and health informatics, with dual focus on kidney stone pathophysiology and health data communication. She investigates microbial entombment in urolithiasis, in vivo stone dissolution mechanisms, and develops visual hierarchies for health data. Additional interests include bedside art interventions for oncology patients and translational studies in diabetic gastroparesis, reflecting her commitment to patient-centered innovation. Publication analysis reveals three dominant research trajectories: (1) Geobiological studies of kidney stones (2018-2021) demonstrating microbial roles in biomineralization, (2) Health informatics work (2023-2024) addressing infodemics and data visualization, and (3) Clinical interventions (2014-2018) exploring pharmacological pathways and non-pharmacological therapies. Her work consistently bridges basic science with clinical applications in renal health and patient experience optimization.